Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022851
Filing Date
2020-05-07
Accepted
2020-05-07 16:10:44
Documents
63
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 CUE-Q1-2020 cue-10q_20200331.htm 10-Q 1151363
2 EX-31.1 cue-ex311_8.htm EX-31.1 15545
3 EX-31.2 cue-ex312_6.htm EX-31.2 15791
4 EX-32.1 cue-ex321_7.htm EX-32.1 10524
5 GRAPHIC gsokbnyncxzs000001.jpg GRAPHIC 23922
  Complete submission text file 0001564590-20-022851.txt   5079311

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cue-20200331.xml EX-101.INS 949992
7 XBRL TAXONOMY EXTENSION SCHEMA cue-20200331.xsd EX-101.SCH 50410
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cue-20200331_cal.xml EX-101.CAL 38199
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cue-20200331_def.xml EX-101.DEF 180616
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20200331_lab.xml EX-101.LAB 390158
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20200331_pre.xml EX-101.PRE 312275
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38327 | Film No.: 20856445
SIC: 2834 Pharmaceutical Preparations